阳普医疗,300030,收入构成,报告日期,2020-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 真空采血系统,11479,7623,3855,33.59%,18.99% 仪器,1053,468,584,55.53%,2.88% 微生物标本处理系统,8178,3287,4891,59.8%,24.09% 试剂,2608,1444,1164,44.62%,5.73% 软件产品及服务,1868,1141,727,38.93%,3.58% 融资租赁,1033,0,1033,99.98%,5.09% 其他产品,3065,1274,1791,58.44%,8.82% 口罩,10899,4641,6257,57.42%,30.82% 阳普医疗,300030,收入构成,报告日期,2019-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 融资租赁,2169,48,2120,97.76%,8.5% 真空采血系统,36213,21883,14330,39.57%,57.42% 软件产品及服务,4019,1831,2188,54.44%,8.77% 其他产品,2404,1421,983,40.88%,3.94% 试剂,9061,5358,3703,40.87%,14.84% 仪器,3641,2008,1633,44.85%,6.54% 阳普医疗,300030,收入构成,报告日期,2019-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 融资租赁,1066,36,1030,96.61%,9.01% 真空采血系统,16067,9754,6313,39.29%,55.23% 软件产品及服务,1844,897,947,51.37%,8.29% 仪器销售,1672,920,752,44.97%,6.58% 其他产品,1032,427,605,58.63%,5.29% 试剂销售,4253,2469,1784,41.95%,15.61% 阳普医疗,300030,收入构成,报告日期,2018-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他产品,2039,1384,655,32.11%,2.93% 试剂,9405,5796,3609,38.38%,16.14% 融资租赁,3049,647,2402,78.78%,10.74% 真空采血系统,33617,20433,13184,39.22%,58.97% 软件产品及服务,2998,2164,834,27.82%,3.73% 仪器,3888,2215,1673,43.03%,7.48% 阳普医疗,300030,收入构成,报告日期,2018-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他产品,1204,959,245,20.37%,2.13% 试剂销售,4261,2510,1751,41.1%,15.19% 融资租赁,1607,346,1261,78.46%,10.94% 仪器销售,1659,844,815,49.14%,7.08% 软件产品及服务,1772,604,1168,65.92%,10.14% 真空采血系统,15408,9124,6285,40.79%,54.53% 阳普医疗,300030,收入构成,报告日期,2017-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 真空采血系统,30730,18207,12523,40.75%,51.01% 软件产品及服务,5800,2246,3554,61.28%,14.48% 仪器,3504,2198,1306,37.28%,5.32% 试剂,10119,5884,4235,41.85%,17.25% 其他产品,1557,1234,322,20.71%,1.31% 融资租赁,3255,645,2610,80.19%,10.63% 阳普医疗,300030,收入构成,报告日期,2017-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),125,49,76,60.48%,0.67% 其他产品,623,595,28,4.54%,0.25% 软件产品及服务,2058,388,1669,81.14%,14.88% 融资租赁,1542,327,1214,78.77%,10.83% 试剂销售,4499,2448,2052,45.6%,18.29% 仪器销售,1225,668,557,45.5%,4.97% 真空采血系统,13428,7808,5621,41.86%,50.11% 阳普医疗,300030,收入构成,报告日期,2016-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他产品,1114,659,455,40.83%,1.89% 软件产品及服务,4667,1297,3370,72.2%,14% 融资租赁,2211,55,2156,97.51%,8.96% 试剂,9873,5343,4530,45.88%,18.82% 仪器,5061,3813,1249,24.67%,5.19% 采血针,4191,3830,361,8.6%,1.5% 采血管,24593,12649,11944,48.57%,49.64% 阳普医疗,300030,收入构成,报告日期,2016-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),54,28,26,48.92%,0.26% 其他产品,818,478,340,41.53%,3.37% 软件产品及服务,1739,358,1381,79.42%,13.7% 融资租赁,857,0,857,100%,8.5% 试剂销售,4543,2445,2098,46.19%,20.82% 仪器销售,1903,1667,235,12.37%,2.34% 采血针,1506,1448,58,3.84%,0.57% 采血管,10988,5905,5082,46.25%,50.43% 阳普医疗,300030,收入构成,报告日期,2015-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),-- ,30,-- ,--,0% 其他产品,2709,1549,1160,42.81%,5.37% 软件产品及服务,1973,595,1378,69.87%,6.38% 融资租赁,2110,-- ,-- ,--,0% 试剂,11982,6500,5482,45.75%,25.38% 仪器,10009,7808,2200,21.99%,10.19% 采血针,3395,2878,516,15.21%,2.39% 采血管,22358,11493,10865,48.6%,50.3% 阳普医疗,300030,收入构成,报告日期,2015-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),8,-- ,-- ,--,0% 代理产品及其他,833,453,380,45.6%,3.85% 仪器销售,4014,2975,1038,25.87%,10.54% 试剂销售,5565,3252,2313,41.56%,23.47% 采血管,10241,5385,4856,47.42%,49.27% 采血针,1464,1215,249,17.02%,2.53% 融资租赁收入,1020,0,1020,100%,10.34% 阳普医疗,300030,收入构成,报告日期,2014-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 融资租赁,564,-- ,-- ,--,0% 仪器销售,9339,6914,2425,25.97%,12.49% 采血管,20661,10461,10200,49.37%,52.53% 代理产品及其他,4565,2273,2292,50.21%,11.8% 采血针,2571,2169,402,15.62%,2.07% 其他(补充),34,-- ,-- ,--,0% 试剂销售,8444,4345,4099,48.54%,21.11% 阳普医疗,300030,收入构成,报告日期,2014-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),7,-- ,-- ,--,0% 其他,1197,702,495,41.36%,6.55% 试剂销售,4136,2211,1925,46.55%,25.46% 仪器销售,3705,2729,976,26.34%,12.9% 采血针,1019,922,97,9.52%,1.28% 采血管,9489,5420,4070,42.89%,53.81% 阳普医疗,300030,收入构成,报告日期,2013-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),21,-- ,-- ,--,0% 代理产品及其他,3077,1623,1455,47.28%,8.75% 试剂销售,8665,4397,4268,49.26%,25.66% 仪器销售,5918,3988,1930,32.61%,11.6% 采血针,2327,1946,381,16.39%,2.29% 采血管,19665,11068,8598,43.72%,51.69% 阳普医疗,300030,收入构成,报告日期,2013-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),8,-- ,-- ,--,0% 代理产品及其他,488,323,164,33.7%,2.6% 试剂销售,3224,1665,1559,48.36%,24.64% 仪器销售,2424,1320,1104,45.56%,17.45% 采血针,972,839,133,13.66%,2.1% 采血管,8138,4771,3367,41.37%,53.22% 阳普医疗,300030,收入构成,报告日期,2012-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),16,-- ,-- ,--,0% 代理产品及其他,1293,929,364,28.16%,2.75% 试剂销售,5293,2393,2899,54.78%,21.92% 仪器销售,4954,2727,2226,44.94%,16.83% 采血针,1851,1544,308,16.61%,2.33% 采血管,17002,9571,7431,43.71%,56.18% 阳普医疗,300030,收入构成,报告日期,2012-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),6,-- ,-- ,--,0% 代理产品及其他,943,555,388,41.12%,7.04% 仪器销售,1247,600,647,51.89%,11.75% 采血针,874,721,153,17.53%,2.78% 试剂销售,2197,1201,997,45.36%,18.1% 采血管,7626,4303,3322,43.57%,60.33% 阳普医疗,300030,收入构成,报告日期,2011-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),27,-- ,-- ,--,0% (5)代理产品及其他,1569,1216,353,22.52%,3.21% (4)试剂销售,2680,1415,1265,47.22%,11.51% (3)仪器销售,3269,1412,1857,56.81%,16.89% (2)采血针,1708,1316,392,22.95%,3.56% (1)采血管,15711,8583,7128,45.37%,64.82% 阳普医疗,300030,收入构成,报告日期,2011-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),2,-- ,-- ,--,0% 尿液分析仪,456,137,319,70%,7.18% 代理产品及其他,1890,972,918,48.56%,20.65% 采血针,627,540,87,13.94%,1.97% 采血管,6834,3714,3120,45.65%,70.21% 阳普医疗,300030,收入构成,报告日期,2010-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 代理产品及其他,3481,2158,1323,38.01%,17.92% 采血针,1319,960,359,27.24%,4.87% 采血管,11776,6074,5702,48.42%,77.22% 阳普医疗,300030,收入构成,报告日期,2010-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 代理产品及其他,936,459,476,50.91%,16.27% 采血针,479,361,119,24.75%,4.05% 采血管,4899,2566,2333,47.63%,79.69% 阳普医疗,300030,收入构成,报告日期,2009-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 代理产品及其他,2894,1839,1055,36.46%,16.07% 采血针,1008,759,249,24.72%,3.79% 采血管,10162,4900,5262,51.78%,80.13% 阳普医疗,300030,收入构成,报告日期,2009-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 代理产品及其它,990,600,390,39.42%,13.03% 采血针,466,335,132,28.22%,4.39% 采血管,4751,2278,2473,52.05%,82.58% 阳普医疗,300030,收入构成,报告日期,2008-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 代理产品及其它,1483,844,638,43.07%,13.35% 采血针,992,752,239,24.12%,5% 采血管,7846,3940,3906,49.78%,81.65% 阳普医疗,300030,收入构成,报告日期,2007-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 代理产品及其它,1023,659,364,35.6%,10.14% 采血针,622,530,92,14.78%,2.56% 采血管,5587,2453,3133,56.09%,87.3% 阳普医疗,300030,收入构成,报告日期,2006-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 代理产品及其它,931,495,436,46.83%,17.36% 采血针,436,367,68,15.71%,2.72% 采血管,3032,1025,2007,66.2%,79.92%